Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hydrolysed diets 'may be beneficial' for feline vomiting and/or diarrhoea
Cats with chronic vomiting and diarrhoea may benefit from a hydrolysed diet.
Researchers assess cats prescribed a hydrolysed diet before antibiotic treatment.

Cats with chronic vomiting and diarrhoea may benefit from a hydrolysed diet before antibiotic and/or glucocorticoid therapy, according to new research.

The study, published in the Journal of Small Animal Practice (JSAP), describes the responses of cats prescribed a hydrolysed diet with or without concurrent antibiotic and/or glucocorticoid for chronic vomiting and/or diarrhoea of undetermined aetiology. 

JSAP editor Nicola Di Girolamo, said: “The results of this study are particularly prudent with the increased awareness and understanding of the role that companion animal veterinary surgeons can play in preventing the development of antimicrobial resistance.”

In the study, researchers at the Royal Veterinary College (RVC) reviewed the medical records of some 5,000 cats with evidence of receiving a hydrolysed diet for gastrointestinal indication, prior and concurrent medication and response after hydrolysed dietary intervention.

Poor response was defined as evidence of receiving antibiotic or glucocorticoid treatment for vomiting and/or diarrhoea at visits after the onset of the diet, or death from gastrointestinal signs for a follow-up period of at least six months. Researchers found that 42 per cent of cats that were first prescribed a hydrolysed diet with or without concurrent antibiotic and/or glucocorticoid had a poor response. 

Dr Aarti Kathrani, a senior lecturer in Small Animal Internal Medicine at the RVC, and corresponding author of the paper explained: “Antibiotic and/or glucocorticoid administration before and concurrent with the diet were associated with higher odds of a poor response. 

“Although our study was unable to determine the causality behind this association, possible explanations may include the association of antibiotic and glucocorticoid treatment with severity of GI signs, prescribing habits of veterinary surgeons, or the effects of antibiotic and glucocorticoids on the intestinal microbiota and mucosal immune system, respectively reducing the effectiveness of a hydrolysed diet.”

Nicola Di Girolamo added: “Although the information available did not allow the authors to correct for the severity of the condition of the individual cats, and this fact could have biased the results if cats that had a more severe condition -and therefore more likely to have a poorer outcome - were immediately prescribed additional medications other than the hydrolysed diet. 

“These results are a base for further randomised controlled trials and provide useful guidance for veterinary surgeons facing similar situations.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.